Article info
PDFOriginal article
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme
- Correspondence to: Dr J M S Bartlett Endocrine Cancer Group, Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK; John.Bartlett{at}ed.ac.uk
Citation
External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme
Publication history
- Accepted August 10, 2006
- First published September 8, 2006.
Online issue publication
June 27, 2007
Article Versions
- Previous version (8 September 2006).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 Journal of Clinical Pathology